series-c-plus
Stage
2015
Founded
1
Investors
About
Elsalys Biotech is a clinical-stage biotechnology company developing novel immunotherapies for cancer. It focuses on targeting the tumor microenvironment and immune checkpoints to create new treatment options.
Explore Elsalys Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.